...
首页> 外文期刊>Vaccine >Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins
【24h】

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins

机译:基于alphavirus载体的复制子颗粒,表达多价交叉保护兰萨病毒糖蛋白

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Vaccine》 |2018年第5期|共8页
  • 作者单位

    Department of Pharmacology and Toxicology School of Medicine Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases NIH Regional Bio-containment Laboratory University of Louisville;

    Department of Pharmacology and Toxicology School of Medicine Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases NIH Regional Bio-containment Laboratory University of Louisville;

    Medigen Inc.;

    Medigen Inc.;

    Department of Pharmacology and Toxicology School of Medicine Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases NIH Regional Bio-containment Laboratory University of Louisville;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 other
  • 中图分类 医学免疫学;
  • 关键词

    Multivalent Lassa virus vaccine; T cells cross-reactivity; protection; Alphavirus replicons;

    机译:多价兰萨病毒疫苗;T细胞交叉反应性;保护;alphavirus复制品;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号